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Abstract We have previously identified a cytosolic protein, 
erythropoietin RNA binding protein (ERBP), which is up-regu- 
lated in certain tissues in response to hypoxia. To further charac- 
terize the interaction of ERBP and erythropoietin (EPO) mRNA, 
we have examined the role of reduction-oxidation i  the EPO 
mRNA binding mechanism of ERBP isolated from human 
hepatoma cells (Hep3B). Reducing agents dithiothreitol (DTT) 
and 2-mercaptoethanol (2-ME) increased ERBP binding activity 
in a concentration-dependent manner, whereas the oxidizing 
agent, diamide, abolished ERBP binding activity. In addition, 
treatment of Hep3B cell lysates with the irreversible suifhydryl 
alkylating agent N-ethylmaleimide resulted in inhibition of 
the EPO mRNA-ERBP complex. Taken together, these findings 
suggest that sulfhydryi groups may play a role in vivo in the 
regulation of EPO production through the modulation of ERBP 
binding activity. 
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1. Introduction 
Post-transcriptional regulation of EPO production has been 
observed [1], and the regulatory mechanisms for control at this 
level of gene expression are currently being investigated. The 
modulation of mRNA turnover rates is an important mecha- 
nism of gene control which may directly influence cytokine/ 
growth factor secretion by altering the amount of translatable 
RNA [2]. Specific cis elements have been identified that directly 
affect mRNA lability, while trans factors have been shown to 
bind to both 5' and 3' untranslated regions (UTR) of target 
mRNAs.  Examples of these types of factors include AUBF,  
which stabilizes AUUUA sequences in GM-CSF;  interferon-),; 
interleukin-3; c-fos; and v-myc mRNAs [3 5], and IRE-BP that 
binds to iron responsive lements in the 5' -UTR of ferritin 
mRNA and the 3 ' -UTR of transferrin receptor mRNA [6]. We 
have previously identified a cytosolic protein that binds specif- 
ically to the 3 ' -UTR of EPO mRNA [7] and is up-regulated by 
hypoxia in certain tissues. Although this protein, called ERBR 
is proposed to affect the stability of EPO mRNA,  its specific 
roles have not been elucidated. Because both AUBF and IRE- 
BP have been shown to be affected by reduction-oxidation 
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"Abbreviations." EPO, erythropoietin; ERBP, erythropoietin RNA bind- 
ing protein; DTT, dithiothreitol; 2-ME, 2-mercaptoethanol; AUBF, 
adenosine-uridine binding factor; GM-CSF, granulocyte-macrophage 
colony-stimulating factor; IRE-BE iron-responsive element-binding 
protein; Y-UTR, Y-untranslated region; MEM, minimal essential me- 
dium; FBS, fetal bovine serum; NEM, N-ethylmaleimide; PBS, phos- 
phate buffered saline. 
[5,8], we examined the possibility that ERBP was similarly 
regulated by changes in redox. 
2. Materials and methods 
2,1. Cell culture 
Hep3B cells obtained from ATCC (Rockville, MD) were routinely 
cultured in Eagle's MEM supplemented with 10% fetal bovine serum, 
0.1 mM non-essential mino acids, 1 mM sodium pyruvate, 100 U/ml 
penicillin G, and 100 pg/ml streptomycin a humidified atmosphere 
of 5% CO_,, 95% air at 37°C. Media and all supplements were purchased 
from Life Technologies Inc. (Gaithersburg, MD). Hypoxic conditions 
were obtained by placing cells in a hypoxie chamber (Billups-Ro- 
thenburg, Del Mar, CA) (1% 02. 5% CO2, 94% N2) for 8 h. 
2.2. Preparation of lysates 
After trypsinization (0.05% trypsin and 0.53 mM EDTA; Gibco), 
Hep3B cells were pelleted at 800 rpm and washed twice with PBS 
(without calcium and magnesium). Following the second wash, the cells 
were gently resuspended, transferred to an Eppendorf tube, pelleted at 
1000 xg for 5 10 s, PBS removed and 25 mM Tris (pH 7.9), 0.5 mM 
EDTA added so that the final concentration was about 2.0 x l0 s cells/ 
/11. Cells were frozen and thawed through repetitive cycles [7]. The 
protein concentration ofeach cytoplasmic lysate was determined using 
the micro BCA (Pierce, Rockford, IL) or Bradford (Bio-Rad, Irving, 
CA) methods, as described by the manufacturer. 
2.3. In vitro transcription 
EPO cDNA was kindly provided by Dr. Jerry Powell (University of 
California, Davis, CA) and subcloned into the EcoRI site of pcDNAI 
(Invitrogen, San Diego, CA). Radiolabeled EPO mRNA was produced 
by T7 RNA polymerase (Promega) from 1 ,ug XhoI-digested pcDNAI 
containing EPO cDNA at the EcoRI site and labeled with [32p]UTP [7]. 
Following phenol/chloroform extraction, transcription mixtures were 
passed through push-trap columns (Stratagene, La Jolla, CA). Specific 
activity was typically 107 cpm/pg mRNA. 
2.4. Band-shift assay 
2 ,ug of cytoplasmic lysate were incubated for 10 min with reducing 
agents, oxidizing agents, or vehicles followed by 5 x 104 cpm of EPO 
mRNA in 12 mM HEPES (pH 7.9), 10% glycerol, 15 mM KC1, 0.25 
mM EDTA, 5 mM MgCI: and 200,ug/ml yeast ransfer RNA in a total 
volume of 10pl for 10 min at 30°C. Twenty units RNase T1 were added, 
and reaction mixtures were incubated for an additional 30 min at 37°C 
prior to electrophoresis in a 7% native polyacrylamide g l with 0.25 x 
TBE (Tris-borate-EDTA) running buffer. After drying, gels were ex- 
posed overnight to film (Amersham-Hyperfilm) with two intensifying 
screens. For quantitation of resulting el band-shift bands the dried gel 
was exposed to a phosphorimaging board (Fuji Photo Co., Japan) for 
30 min to 1 h, and the results were analyzed using MacBAS analyzing 
software. 
3. Results 
3.1. Comparison of  normoxic and hypoxic lysates treated with 
various concentrations of  DTT  and 2 -ME 
It has been hypothesized that ERBP plays a role in EPO 
mRNA activity [7] and that it may mediate ribonuclease activity 
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Fig. 1. Effects of dithiothreitol. Hep3B lysates were prepared from cells 
harvested after 8 h normoxic or hypoxic stimulus as described in section 
2. Subsequently, these lysates were pretreated for 10 min with varying 
concentrations of DTT (0-10 mM) prior to gel band-shift assay and 
separation on 7% native polyacrylamide g l as described in section 2. 
Radioactive values for each band were obtained after exposing the 
dried gels to a Fuji phosphorimaging board. The data presented are the 
means of duplicate samples performed with lysates from three inde- 
pendent experiments. Standard error values for each sample are: 
normoxia, 0.1 mM (+0.133), 1mM (+0.37), 10 mM (+0.82); hypoxia, 
0.1 mM (_+0.59), 1.0 mM (_+0.34), and 10 mM (+_ 1.38). The insert 
shown is a representative autoradiogram used in data analysis. 
[1]. However, it is not known how the binding activity of ERBP 
is regulated, or if other factors recruited or bound to ERBP 
regulate its activity. In addition, it is known that the EPO 
mRNA concentration reaches a peak level after 5-8 h of hy- 
poxia [1], suggesting that the effect of ERBP on EPO mRNA 
should occur at this time. In order to investigate the redox 
status of ERBP, normoxic and hypoxic (8 h) lysotes were 
treated with various concentrations of DTT (0-10 raM) and 
2-ME (0 10%), and their ERBP binding activity was assessed 
by band-shift assay. Fig. 1 shows that there is a dose-dependent 
increase in EPO mRNA binding by ERBP as a result of increas- 
ing amounts of DTT. In addition, this effect is observed in both 
normoxic and hypoxic treated lysates. Similarly, treatment with 
increasing amounts of 2-ME resulted in increasing ERBP bind- 
ing activity (Fig. 2). At 10% 2-ME treatment, a smear attributed 
to denaturing of the whole cell lysate was consistently observed. 
These results suggest hat ERBP-EPO mRNA binding might 
involve prior, local reduction of ERBP's sulfhydryl groups. 
3.2. Effect of  reducing and oxidizing agents on the J+)rmation of 
ERBP-EPO mRNA complex 
To determine further the effect of reducing and oxidizing 
agents on the formation of ERBP-EPO mRNA complex, 2 #g 
of normoxic Hep3B lysates were pre-incubated for 10 rain at 
30°C with 0.2 mM DTT, 1% 2-ME or the oxidizing agent 
diamide (1 or 5 mM), with or without 1% 2-ME prior to the 
addition of radiolabeled EPO mRNA. This treatment was fol- 
lowed by RNase T1 digestion, electrophoresis and autoradi- 
ography. As above, treatment of lysates with DTT or 2-ME 
resulted in an increase in ERBP binding activity whereas treat- 
ment with diamide abolished ERBP binding activity. Binding 
activity after diamide treatment could be restored by a brief 
incubation with 0.1% 2-ME. A representative band-shift assay 
is shown in Fig. 3. The observed slower migrating band has 
been shown previously [7] to be competed out with GM-CSF 
mRNA transcripts, and its relationship to EPO mRNA binding 
is still being investigated. These data indicate that alteration in 
the redox state of the cytoplasmic lysate affects ERBP binding 
activity. 
3.3. Effect of N-ethylmaleimide (NEM), an irreversible 
oxidizing agent, on the formation of  ERBP EPO mRNA 
complex 
Reduced sulfhydryl groups can function in different ways. 
We have previously demonstrated that ERBP is composed of 
two subunits, 70 and 130-140 kDa, that may be attached via 
intermolecular disulfide bonds [7]. Likewise, AUBF is com- 
posed of three subunits, and redox changes appear to affect its 
intermolecular disulfide bonds [5], while redox changes appear 
to affect sulfhydryl groups on IRE-BP that mediate ligand 
binding [8]. In order to determine which of these possible inter- 
actions is operative for ERBP-EPO mRNA complex forma- 
tion, Hep3B lysates were treated with NEM prior to band-shift 
assay. NEM differs from diamide by irreversibly alkylating 
reduced sulfhydryl groups. In addition, NEM has no effect on 
-SH groups of mRNA binding proteins involved in transient 
Michael adduct formation with ligands [8]. As shown in Fig. 
4, pre-incubation of lysates with NEM completely abolished 
ERBP binding activity. NEM added after ERBP-EPO mRNA 
complexes were formed did not inhibit binding, although it 
seems to have decreased the binding activity. The effects ob- 
served after combination treatment with 2-ME are not as 
straightforward and may reflect partial activation of free, unal- 
kylated sulfhydryl groups within ERBP. These observations 
suggest hat the -SH groups of ERBP might be involved in the 
ERBP binding site as they appear to be for IRE-BE Addition- 
ally, there might be -SH groups, the redox state of which might 
affect complex formation, residing elsewhere on the protein. 
4. Discuss ion 
In order to better understand the functions of ERBP in EPO 
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Fig. 2. Effects of 2-mercaptoethanol. Comparison of normoxic and 
hypoxic (8 h) lysates treated with various concentrations of 2-ME. 
Reaction mixtures were as described, except for the pretreatment of he 
lysates with different concentrations of 2-ME for 10 min prior to the 
addition of the radiolabeled EPO mRNA. The standard error values 
for each sample are: normoxia, 0.1 mM (+0.19), 1.0 mM (+0.24); 
hypoxia, 0.1 mM (+0.42), and 1.0 mM (+0.67). (Consistently, 10 mM 
2-ME treatment of the lysates resulted in a retention of large protein 
complexes in the native gel. For this reason, this particular sample has 
been omitted from the densitometric data graph.) The arrow indicates 
ERBP EPO mRNA complex. 
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Fig. 3. Effect of reducing and oxidizing agents on the formation of 
ERBP EPO mRNA complex. Normoxic Hep3B cytoplasmic lysates 
from near confluent cultures were prepared by freeze-thaw lysis as 
described in section 2. mRNA was transcribed by T7 RNA polymerase 
and labeled with [32p]UTP from XhoI-digested pcDNA! containing 
EPO cDNA at the EcoRI sites. 2/lg of cytoplasmic lysate were incu- 
bated for 10 min with reducing agents, oxidizing agents or vehicle 
followed by 5 x 104 cpm of mRNA in 12 mM HEPES and 200/lg/ml 
E. coli transfer mRNA in a total volume of 10/tl for 10 min at 30°C. 
Twenty units mRNase TI were added, and reaction mixtures were 
incubated for an additional 30 min at 37°C prior to electrophoresis in 
a 7% native polyacrylamide g l with 0.25 x TBE running buffer. After 
drying, the gel was exposed overnight to film. Lane 1, vehicle/control; 
lane 2, 0.2 mM DTT; lane 3, 1% 2-ME; lane 4, 5 mM diamide; lane 5, 
1 mM diamide; lane 6,7, 5 and 1 mM diamide, respectively, followed 
by an additional 10 min incubation with 1% 1-ME. The arrow indicates 
ERBP-EPO mRNA complex. 
mRNA stability, we examined the regulation of this protein in 
response to changes in reduction oxidation conditions, which 
are known to affect other mRNA binding proteins. ERBP 
binding activity is sensitive to changes in redox since reducing 
agents increase binding activity and oxidizing agents abolish it. 
We conclude that free sulfhydryl groups are required for 
ERBP-EPO mRNA complex formation. These -SH groups 
most likely form transient Michael adducts with mRNA,  since 
NEM does not affect an already formed ERBP EPO mRNA 
complex. This observation is consistent with those reported for 
other mRNA binding proteins, such as the coat protein of R17 
coliphage [9] and the phage replicase mRNA between the E. coli 
AIa-t-RNA synthetase and its target RNA [10], and between 
the mammalian IRE-BP and the IRE [8]. Treatment of both 
normoxic and hypoxic (8 h) lysates with reducing agents re- 
sulted in a concentration-dependent increase in complex forma- 
tion. However, over the course of the experiments here seemed 
to be a slightly greater magnitude of activatable ERBP in 
treated hypoxic lysates. It is possible that the hypoxic treatment 
results in the production of greater amounts of reduced ERBP. 
Interestingly, the differences seen with 2-ME treatment of 
normoxic lysates compared with hypoxic lysates were observed 
only after 5 8 h of hypoxic treatment; it was not seen at later 
times (20 h). The 5 8 h range coincides with the period reported 
to have the highest amount of EPO mRNA [1]. These observa- 
tions strongly suggest hat hypoxia affects the binding of ERBP 
by changes in redox. Previous studies from our laboratory have 
shown that reactive oxygen metabolites cause an increase in 
EPO production in renal carcinoma cells [11]. These reactive 
oxygen metabolites may be generated uring discontinuous 
hypoxia, a relatively more effective means of generating EPO 
than is continuous hypoxia. McCord [12] has demonstrated 
that reactive oxygen metabolites accumulate following reperfu- 
sion and reoxygenation of blood flow in the kidney. It is also 
possible that the waxing and waning of flow could provide for 
the formation of reactive oxygen metabolites. In addition, it is 
believed that two major factors determine the redox state of 
sulfhydryl groups within the cytosol. One is the ratio of re- 
duced-to-oxidized glutathione [13], and the second is the oxida- 
tion equilibrium constant for a particular sulfhydryl group 
within a protein. The equilibrium constant can vary over many 
orders of magnitude, reflecting the effects of a local environ- 
ment around the cysteinyl moiety on its kox [14]. Conforma- 
tional changes, such as interactions with the heat shock 
proteins (e.g. hsp70), can alter the local environment of the 
cysteinyl moiety and, therefore, affect the kox of a particular 
-SH group. 
1234 
Fig. 4. Effect of N-ethylmaleimide, an irreversible oxidizing agent, on 
the formation of ERBP EPO mRNA complex. Reaction mixtures were 
as described in Fig. 2, except for the pretreatment of the lysates. Lane 
1, vehicle; lane 2, 1 mM NEM; lane 3, 1 mM NEM followed by 10 min 
incubation with 1% 2-ME; lane 4, treatment of the mixture with 1 mM 
NEM after the complex has already formed. The arrow indicates 
ERBP-EPO mRNA complex. 
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ERBP regulation thus far appears to be very similar to that 
of AUBF  and IRE-BE That is, the activity of these proteins 
is not related to a change in their synthesis but rather to post- 
translational modifications, such as phosphorylation for 
AUBF  [5] and sensitivity to iron [15] and hemin [16], as is the 
case for IRE-BEE The mechanisms of ERBP regulation are 
undoubtedly as complex as they are for AUBF  and IRE-BE 
In this study, we demonstrate that in vitro detection of ERBP 
binding activity is dependent on a reducing environment. Con- 
versely, binding activity can be abolished by the reversible ox- 
idizing agent, diamide, and reconstituted by DTT or 2-ME. 
While these experiments were conducted on crude lysates and 
thus must be cautiously interpreted, the data suggest hat alter- 
ations of ERBP's redox state may participate in the regulation 
of the protein's binding activity. Details on the mechanisms for 
its regulation await purification of ERBP. Although the effect 
of ERBP on EPO mRNA half-life has not yet been determined, 
we propose that the binding of ERBP to EPO mRNA subse- 
quently targets EPO mRNA for degradation and, thus, EPO 
production is limited; whereas, during hypoxia, sulfhydryl 
groups on ERBP are not accessible for ERBP to interact with 
EPO mRNA and, as a result, EPO mRNA accumulates, result- 
ing in an increase in EPO production. 
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